Who are Triptoreline's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Eligard, Tryptorelin, Orilissa.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/triptoreline.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Triptoreline — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Triptoreline (Triptoreline) competitive landscape: 3 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Area: Oncology.

phase 2 Gonadotropin-releasing hormone receptor, Gonadotropin-releasing hormone receptor Oncology Small molecule Live · refreshed every 30 min

Target snapshot

Triptoreline (Triptoreline) — Universitaire Ziekenhuizen KU Leuven.

Comparator set (3 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Target
Triptoreline TARGET	Triptoreline	Universitaire Ziekenhuizen KU Leuven	phase 2	Gonadotropin-releasing hormone receptor, Gonadotropin-releasing hormone receptor
Eligard	Eligard	Astellas Pharma Europe Ltd.	marketed	Gonadotropin-releasing hormone receptor, Gonadotropin-releasing hormone receptor
Tryptorelin	Tryptorelin	Instituto Valenciano de Infertilidad, IVI VALENCIA	marketed	Gonadotropin-releasing hormone receptor, Gonadotropin-releasing hormone receptor
Orilissa	Orilissa	University of Wisconsin, Madison	marketed	Gonadotropin-releasing hormone receptor, Gonadotropin-releasing hormone receptor

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape

No sponsor landscape data.

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Triptoreline — Competitive Intelligence Brief. https://druglandscape.com/ci/triptoreline. Accessed 2026-06-10.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing